异形性早发性心室复合体治疗: 弗莱卡因尼德,普罗帕芬和索塔洛的比较
Dejan Kojić1, Anja Radunović1, Zoran Bukumirić2
1Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia.
Clinical cardiology
|August 3, 2023
概括
弗莱凯尼德在减少早产腹腔综合体 (PVCs) 方面表现出优异的疗效,与普罗帕芬和索塔洛尔相比. 这项研究强调了flekainide作为一种更有效的抗心律失常药物,用于特异性PVC.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 电子生理学 电子生理学
背景情况:
- 异常性早发性心室复合体 (PVCs) 通常用β-阻断剂 (BB) 或通道阻断剂 (CCB) 治疗,这些药物具有有限的疗效.
- 类 Ic 的抗节律药物 (AAD) 提供中等到高效率,但支持证据很少.
研究的目的:
- 为了比较flekainide,propafenone (Ic类) 和sotalol (III类) 的有效性和安全性,用于治疗有症状的异常性PVC.
主要方法:
- 一个单一中心的回顾性研究包括了104名患者,其中130名患者有频繁的异常性PVC的药物治疗发作.
- 患者接受了 flecainide,propafenone 或 sotalol 的治疗.
- 评估结果是完全/几乎完全减少PVC (>99%) 和显著减少 (≥80%).
主要成果:
- 弗莱卡尼德在56%的患者中实现了99%以上的PVC负担减轻,远远超过了普罗帕芬 (11%) 或索塔醇 (21%).
- 对于≥80%的PVC负担减轻,flekainide在64%的患者中是有效的,相比之下,propafenone为30%,sotalol为33%.
- 在普罗法和索塔醇之间没有观察到有效性的显著差异.
结论:
- 类Ic和III的抗节律药物 (AADs) 对异常性PVCs具有适度的疗效.
- 弗莱卡尼德是研究中最有效的AAD,可以显著或几乎完全减少PVC负担.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.8K
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
17.4K
相关概念视频
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
45
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
45
01:25Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
01:28Dysrhythmias II: Classification of Tachyarrhythmias
11
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
11
01:30Dysrhythmias V: Evaluating Dysrhythmias
42
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
01:15Dysrhythmias I: Introduction
14
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
14